Weight Gain Linked to Hot Flashes After Breast Cancer

Share this article:
Weight Gain Linked to Hot Flashes After Breast Cancer
Weight Gain Linked to Hot Flashes After Breast Cancer

(HealthDay News) -- Early-stage breast cancer survivors who gain at least 10 percent of their pre-diagnosis weight are significantly more likely to report hot flashes than those who remain weight stable, according to a study published online March 19 in the Journal of Clinical Oncology.

Bette J. Caan, Dr.P.H., of Kaiser Permanente Northern California in Oakland, and colleagues used data from the Women's Healthy Eating and Living study to evaluate the relationship between body weight change after breast cancer diagnosis and hot flashes in 3,088 early-stage breast cancer survivors.

The researchers found that, at study entry, 36.1 percent of women reported moderate-to-severe hot flashes. Two years following their breast cancer diagnosis, women who gained 10 percent or more of their pre-diagnosis body weight were significantly more likely to experience hot flashes than those who maintained their weight (odds ratio, 1.33; P = 0.003). Although not statistically significant, women who lost at least 10 percent of their pre-diagnosis body weight were less likely to experience hot flashes (odds ratio, 0.72; P = 0.118). The trend of weight change on hot flashes was found to be significant.

"Breast cancer survivors who gained 10 percent or more of their pre-diagnosis weight after a breast cancer diagnosis more frequently experienced moderate-to-severe hot flashes than women who remained within 10 percent of their pre-diagnosis weight," the authors write. "In addition, there was a suggestion that weight loss was associated with a reduction of hot flashes."

Abstract
Full Text (subscription or payment may be required)

This article originally appeared here.
Share this article:
You must be a registered member of ONA to post a comment.
close

Next Article in Daily Oncology News

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Daily Oncology News

Challenges exist in treating HPV oropharyngeal cancer patients

Challenges exist in treating HPV oropharyngeal cancer patients

Mixed views have been expressed in relation to explaining the causal role of HPV in oropharyngeal cancer.

Views on Affordable Care Act split by political affiliation

Views on Affordable Care Act split by political ...

Health care is third most important issue to Americans in fall elections, according to polls

Poor staging linked to mortality in bladder cancer

Poor staging linked to mortality in bladder cancer

In cases of bladder cancer, omission of muscle in specimen or its mention in pathology report is linked to increased mortality.